CM
Crestline Management’s Puma Biotechnology PBYI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-35,832
| Closed | -$190K | – | 187 |
|
|
2024
Q1 | $190K | Buy |
35,832
+1,058
| +3% | +$5.61K | 0.02% | 155 |
|
|
2023
Q4 | $151K | Buy |
34,774
+2,135
| +7% | +$9.25K | 0.01% | 152 |
|
|
2023
Q3 | $85.8K | Hold |
32,639
| – | – | 0.01% | 139 |
|
|
2023
Q2 | $115K | Buy |
32,639
+755
| +2% | +$2.67K | 0.01% | 146 |
|
|
2023
Q1 | $98.5K | Buy |
31,884
+3,388
| +12% | +$10.5K | 0.01% | 155 |
|
|
2022
Q4 | $121K | Buy |
28,496
+291
| +1% | +$1.23K | 0.02% | 163 |
|
|
2022
Q3 | $67K | Hold |
28,205
| – | – | 0.01% | 199 |
|
|
2022
Q2 | $80K | Sell |
28,205
-366
| -1% | -$1.04K | 0.01% | 211 |
|
|
2022
Q1 | $82K | Buy |
+28,571
| New | +$82K | 0.01% | 250 |
|
|
2019
Q3 | – | Sell |
-32,000
| Closed | -$407K | – | 100 |
|
|
2019
Q2 | $407K | Buy |
+32,000
| New | +$407K | 0.05% | 75 |
|
|
2018
Q3 | – | Sell |
-18,132
| Closed | -$1.07M | – | 211 |
|
|
2018
Q2 | $1.07M | Buy |
+18,132
| New | +$1.07M | 0.11% | 191 |
|
|
2017
Q3 | – | Sell |
-15,685
| Closed | -$1.37M | – | 164 |
|
|
2017
Q2 | $1.37M | Buy |
15,685
+2,785
| +22% | +$243K | 0.18% | 65 |
|
|
2017
Q1 | $480K | Buy |
+12,900
| New | +$480K | 0.09% | 87 |
|